Popular on EntSun
- Still Using Ice? FrostSkin Reinvents Hydration - 185
- Ice Melts. Infrastructure Fails. What Happens to Clean Water? - 158
- Postmortem Pathology Expands to Phoenix: Bringing Families Answers During Their Most Difficult Moments - 146
- François Arnaud, star of Heated Rivalry, is the real-life inspiration behind Christopher Stoddard's novel At Night Only - 144
- Purple Heart Recipient Honored by Hall of Fame Son In Viral Tribute Sparking National Conversation on Service Fatherhood, Healing and Legacy - 140
- From Boardroom to Broadcast: Vegas Circle Podcast Goes Live in Las Vegas - 139
- Cold. Clean. Anywhere. Meet FrostSkin - 138
- From "Law & Order" to the Lens: Matthew Bennett Photography Redefines the Professional Portrait in Downtown Toronto - 138
- Author, Philanthropist Ethel Gardner Joins Creators' Rights Movement Advisory Board - 134
- HBMHCW Expande Infraestructura de Cumplimiento para Argentina mientras América Latina Supera $1.5 Billones en Volumen Cripto - 133
Similar on EntSun
- NaturismRE Launches the NRE Health Institute to Advance Evidence-Informed Public Health Research
- Progressive Dental & The Closing Institute Partner with Zest Dental Solutions to Elevate Full-Arch Growth and Patient Outcomes
- CCHR: While Damaging Antipsychotics Win Approval, Proven Non-Drug Alternatives Remain Ignored
- At 25, She Became One of the Youngest AAPI Female Founders to Win One of the World's Most Prestigious Design Awards for a Lamp That Makes You Smile
- Triple-Digit Growth, Strategic N A S D A Q Uplist, Plus A Scalable Healthcare Rollout Model: Stock Symbol: CDIX
- Vesica Health Receives FDA Breakthrough Device Designation for AssureMDx
- ClearSight Therapeutics Signs LOI with Covalent Medical for $60M Multi-Channel OTC Eye Care Partnership
- Cummings Graduate Institute for Behavioral Health Studies Honors New Doctor of Behavioral Health Graduates
- IDpack v4 Launches: A Major Evolution in Cloud-Based ID Card Issuance
- CCHR Says Psychiatry's Admission on Antidepressant Withdrawal Comes Far Too Late
NATCO Awarded U.S. Patent for Persimonal® – Breakthrough Innovation in Preparing Persimmon Leaf Extract
EntSun News/11078356
TEMECULA, Calif. - EntSun -- NATCO proudly announces that the United States Patent and Trademark Office (USPTO) has officially granted U.S. Patent No. 12,453,363 B2 for its latest invention, Persimonal®, a proprietary technology for preparing persimmon leaf extract.
This milestone patent underscores NATCO's commitment to advancing botanical science and delivering innovative, clinically relevant solutions in natural health and nutrition. Persimonal® represents a novel approach to harnessing the bioactive compounds of persimmon leaves, long valued in traditional medicine for their antioxidant, anti-inflammatory, and cardiovascular-supportive properties.
Key Highlights of Persimonal®
Executive Statement
More on EntSun News
"The awarding of this U.S. patent validates NATCO's dedication to scientific excellence and innovation in natural product development," said [Abdul Alkayali], [Executive Vice President] at NATCO. "Persimonal® is more than an extraction method—it's a platform for unlocking the full potential of persimmon leaves to support human health."
About NATCO
NATCO is a leader in natural product innovation, specializing in proprietary technologies that transform traditional botanicals into clinically relevant, market-ready solutions. With a focus on science, sustainability, and consumer wellness, NATCO continues to pioneer advancements that set new standards in the nutraceutical industry.
www.natcohealthyliving.com
This milestone patent underscores NATCO's commitment to advancing botanical science and delivering innovative, clinically relevant solutions in natural health and nutrition. Persimonal® represents a novel approach to harnessing the bioactive compounds of persimmon leaves, long valued in traditional medicine for their antioxidant, anti-inflammatory, and cardiovascular-supportive properties.
Key Highlights of Persimonal®
- Patent Protection: U.S. Patent No. 12,453,363 B2 secures NATCO's proprietary process for preparing persimmon leaf extract.
- Scientific Innovation: Persimonal® optimizes extraction to preserve and enhance the potency of polyphenols, flavonoids, and other beneficial compounds.
- Health Potential: Persimmon leaf extract has been studied for supporting vascular health, lowering blood pressure and cholesterol, metabolic balance, and overall wellness.
- Market Differentiation: Persimonal® positions NATCO at the forefront of botanical innovation, offering a unique, patent-backed ingredient for nutraceutical and functional food applications.
Executive Statement
More on EntSun News
- Arcuri Group Announces Long‑Term Partnership with WakeMed Health & Hospitals to Deliver Situational Awareness and De‑escalation Training
- Inside NobleCon 2025: Aiden McNally with Wealth Strategy Media Interviews Chairman Sean P. Jackson
- Ghostlight Ensemble Announces Cast For 'The Dover Road'
- At 25, She Became One of the Youngest AAPI Female Founders to Win One of the World's Most Prestigious Design Awards for a Lamp That Makes You Smile
- Juego Studios Extends Full-Cycle Game Development & Outsourcing Capabilities to the UAE Market
"The awarding of this U.S. patent validates NATCO's dedication to scientific excellence and innovation in natural product development," said [Abdul Alkayali], [Executive Vice President] at NATCO. "Persimonal® is more than an extraction method—it's a platform for unlocking the full potential of persimmon leaves to support human health."
About NATCO
NATCO is a leader in natural product innovation, specializing in proprietary technologies that transform traditional botanicals into clinically relevant, market-ready solutions. With a focus on science, sustainability, and consumer wellness, NATCO continues to pioneer advancements that set new standards in the nutraceutical industry.
www.natcohealthyliving.com
Source: NATCO, Inc
Filed Under: Beauty
0 Comments
Latest on EntSun News
- Embrace Fashion with ZEELOOL's 2026 Spring Sale
- The Raiders House Band Wins Prestigious Clio Sports Award for Game Day Innovation
- New Podcast "Luke at the Roost" Blends AI-Generated Callers with Live Late-Night Radio Format
- Purple Heart Recipient Honored by Hall of Fame Son In Viral Tribute Sparking National Conversation on Service Fatherhood, Healing and Legacy
- iPOP Alum Jacob Batalon Stars in Amazon Prime's "The Wrecking Crew"
- iPOP Alum Olivia Holt Stars in "This Is Not a Test"
- Black women's Wig Trends analysis: Why curlyme 7×5 lace wigs and 360 glueless wigs are the top choice?
- KR38 Creative Expands Development Slate for 2026 Across Film, Streaming, and Live Entertainment
- Amicly Launches as a Safety-First Social App Designed to Help People Build Real, Meaningful Friendships
- Primeindexer Google indexing platform launched by SEO Danmark APS
- Kaltra Introduces New Downward-Spraying Distribution Technology to Boost Microchannel Evaporator Performance
- Talentica Announces Winners of Multi-Agent Hackathon 2026
- Fritz Coleman's Show "Unassisted Residency" Begins Third Year at El Portal Theatre
- Wealth Strategy Media Spotlights Dr. Khalilah Camacho-Ali's Book Signing & Exclusive Appearance
- DJ Rad Talks Strategy, Survival & Success with Wealth Strategy Media - First Voice in 50 Cent Doc
- Special Alert: Undervalued Opportunity: IQSTEL (N A S D A Q: IQST) Positioned for Explosive Multi-Year Growth
- Triple-Digit Growth, Strategic N A S D A Q Uplist, Plus A Scalable Healthcare Rollout Model: Stock Symbol: CDIX
- Vesica Health Receives FDA Breakthrough Device Designation for AssureMDx
- Cygnet Theatre Announces The Cast And Creative Team Of Stefano Massini's The Lehman Trilogy
- Lineus Medical's SafeBreak® Vascular Added to Alliant GPO Contract
